Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD
Clinical trial NCT02680197 · COMPLETED
Trial details
- NCT number
- NCT02680197
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2017-02-06
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.